Kewaunee Scientific Corporation
KEQU · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $70,096 | $71,104 | $77,148 | $67,167 |
| % Growth | -1.4% | -7.8% | 14.9% | – |
| Cost of Goods Sold | $50,376 | $50,174 | $53,110 | $48,788 |
| Gross Profit | $19,720 | $20,930 | $24,038 | $18,379 |
| % Margin | 28.1% | 29.4% | 31.2% | 27.4% |
| R&D Expenses | $0 | $0 | $919 | $0 |
| G&A Expenses | $0 | $0 | $14,626 | $0 |
| SG&A Expenses | $0 | $0 | $15,538 | $16,129 |
| Sales & Mktg Exp. | $0 | $0 | $912 | $0 |
| Other Operating Expenses | $15,613 | $16,120 | -$919 | $0 |
| Operating Expenses | $15,613 | $16,120 | $15,538 | $16,129 |
| Operating Income | $4,107 | $4,810 | $8,500 | $2,250 |
| % Margin | 5.9% | 6.8% | 11% | 3.3% |
| Other Income/Exp. Net | -$654 | -$890 | -$1,351 | -$975 |
| Pre-Tax Income | $3,453 | $3,920 | $7,149 | $1,275 |
| Tax Expense | $915 | $761 | $2,202 | -$108 |
| Net Income | $2,445 | $3,093 | $4,850 | $1,354 |
| % Margin | 3.5% | 4.3% | 6.3% | 2% |
| EPS | 0.85 | 1.08 | 1.7 | 0.47 |
| % Growth | -21.3% | -36.5% | 261.7% | – |
| EPS Diluted | 0.82 | 1.04 | 1.63 | 0.45 |
| Weighted Avg Shares Out | 2,859 | 2,851 | 2,854 | 2,872 |
| Weighted Avg Shares Out Dil | 2,977 | 2,963 | 2,981 | 2,995 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,061 | $1,058 | $1,163 | $1,137 |
| Depreciation & Amortization | $1,580 | $1,549 | $1,575 | $1,563 |
| EBITDA | $6,094 | $6,527 | $9,887 | $3,975 |
| % Margin | 8.7% | 9.2% | 12.8% | 5.9% |